1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Vision, Ocular: new trials by email Literature Review of Vision, Ocular trials Research Report on Vision, Ocular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiation and Combination Immunotherapy for Melanoma Aldesleukin: All Patients, Nivolumab: Cohort 1 (Cutaneous), Nivolumab: Cohort 2 (Ocular) - Metastatic Melanoma | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 4 | 2019-05-28 | 2024-01-17 |
Melanoma (1)
Masonic Cancer Center, University of Minnesota (1)
United States (1)